References
- ElliotKHPaulAMGilbertLROver-the-counter analgesics and antipyretics: a critical assessmentClin Ther20002250054810868553
- CoulthardPPost-operative oral surgery pain: a reviewOral Surg20081167177
- PriyankaABiswajitMDesign, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium saltJ Pharm Sci2002912076208912210054
- MeechanGJEffective topical anesthetic agents and techniquesDent Clin N Am20024675976612436830
- SchwarzCMehnertWLucksJSMullerRHSolid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilizationJ Control Release1994308396
- CuiZMumperRJBilayer films for mucosal (genetic) immunization via the buccal route in rabbitsPharm Res200219794795312180546
- SubediRKKangaKWChoiHKPreparation and characterization of solid lipid nanoparticles loaded with doxorubicinEur J Pharm Sci2009373–450851319406231
- YanFChaoZZhengYLinMLinaTCunxianSThe effect of pluronic F 68 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicityNanomedicine2010617017819447200
- MolpeceresJGuzmanMAberturasMRChaconMBergesLApplication of central composite designs to the preparation of polycaprolactone nanoparticles by solvent displacementJ Pharm Sci1996852062138683450
- NagarajuMPSureshSKshamaDRoopaSPEvaluation of solid lipid nanoparticle formulation on pharmacokinetics, efficacy and toxicity of doxorubicinJ Nanopart Res20131521242131
- NidhiMKusumvalliSKusumdeviVDesign and development of a novel transmucosal patch embedded with diclofenac diethylamine loaded solid lipid nanoparticlesJ Young Pharm2015714555
- EiichiTKikumiWHiroshigeOMakotoHNorihoKMasahiroGIntestinal patches with an immobilized solid-in-oil formulation for oral protein deliveryActa Biomater20128265365821982846
- RahmanZZidanASKhanMANon-destructive methods of characterization of risperidone solid lipid nanoparticlesEur J Pharm Biopharm201076112713720470882
- KesavanBJayaramanAVelayuthamRVobalaboinaVYamsaniMRLipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studiesLipids Health Dis2009811519128464
- HolpuchASHummelGJTongMNanoparticles for local drug delivery to the oral mucosa: proof of principle studiesPharm Res20102771224123620354767
- SupriyaSSNileshSSSagarSVilasraoKMucoadhesive bilayered patches for administration of sumatriptan succinateAAPS Pharm-SciTech200893909916
- EduardoRJMariaBBJulianaMMHPLC assay of lidocaine in in vitro dissolution test of the poloxamer 407 gels. BrazilJ Pharm Sci2002381107111
- AvaniRPManojkumarSTClinical effect of subgingivally delivered simvastatin in the treatment of patients with chronic periodontitis: a randomized clinical trialJ Periodontal2010812214222
- LiewVMackGTsengPCvejicMHaydenMBuchananNSingle-dose concentrations of tinidazole in gingival crevicular fluid, serum, and gingival tissue in adults with periodontitisJ Dent Res19917059109122022773
- NagarajuMPSureshSKshamaDComparison and correlation of in vitro, in vivo and in silico evaluations of alpha, beta and gamma cyclodextrin complexes of curcuminJ Incl Phenom Macrocycl Chem201478471483
- NagarajuMPSureshSKshamaDRoopaSPCombinatorial therapeutic regimen of lipid based curcumin and doxorubicin nanoparticles: implications on antitumor efficacy and drug-induced toxicityJ Nanopharm Drug Deliv20142115
- PankajPMangalNFormulation and evaluation of lidocaine lipid nanosystems for dermal deliveryAAPS PharmSciTech200910398599219641997
- BunjesHUnruhTCharacterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scatteringAdv Drug Deliv Rev20075937940217658653
- ChrysanthaFRainerHMEffect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersionsInt J Pharm19981682221229
- SchwartzJBFlamholzJRPressRHComputer optimization of pharmaceutical formulations I: general proceduresJ Pharm Sci1973627116511674714125
- WelchWJComputer aided design of experiments for response surface estimationTechnometrics1984263217224
- SoutoEBWissingSABarbosaCMMüllerRHDevelopment of a controlled release formulation based on SLN and NLC for topical clotrimazole deliveryInt J Pharm20042781717715158950
- WertzPWSquierCACellular and molecular basis of barrier function in oral epitheliumCrit Rev Ther Drug Carrier Syst1991832372691954652
- ShenQWangYZhangYImprovement of colchicine oral bioavailability by incorporating eugenol in the nanoemulsion as an oil excipient and enhancerInt J Nanomed2011612371243
- WestesenKBunjesHDo nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrixInt J Pharm19951151129131
- AbdelbaryGFahmyRHDiazepam-loaded solid lipid nanoparticles: design and characterizationAAPS PharmSciTech200910121121919277870
- TözümTFYildirimACağlayanFDinçelABozkurtASerum and gingival crevicular fluid levels of ciprofloxacin in patients with periodontitisJ Am Dent Assoc2004135121728173215646608
- SakellariDGoodsonJMKolokotronisAKonstantinidisAConcentration of 3 tetracyclines in plasma, gingival crevice fluid and salivaJ Clin Periodontol2000271536010674962
- Sarkiala-KesselEMJärvinenANokelainenMAsikainenSConcentrations of tinidazole in gingival crevicular fluid and plasma in dogs after multiple dose administrationJ Vet Pharmacol Ther19961931711758803874